West announces fourth-quarter and full-year 2021 results

Exton, pa., feb. 17, 2022 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst) today announced its financial results for the fourth-quarter and full-year 2021 and introduced full-year 2022 financial guidance. fourth-quarter and full-year 2021 summary (comparisons to prior-year period) fourth-quarter 2021 net sales of $730.8 million grew 26.0%; organic sales growth was 28.3%.
WST Ratings Summary
WST Quant Ranking